Jonathan Esensten
Blood Banking & Transfusion Medicine · San Francisco, CANPI 1285900910
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $500 of the $500 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Jazz Pharmaceuticals Inc..
Across 1 payment — averaging $500.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$500
Across 48 payments — averaging $47,145 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk US Research & Development, Inc.$2.3M
What the payments were for
- Consulting fees$500100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 1 | $500 |
How this compares
$500 in reported general payments places this provider in the 75th percentile of 34 blood banking & transfusion medicine providers in California.
See all blood banking & transfusion medicine providers in California →
Other blood banking & transfusion medicine in San Francisco
- Kim-Anh NguyenSan Francisco$84
- Nora HirschlerSan Francisco$46
- Ashok NambiarSan Francisco$24
- Huy PhamLos Angeles$92K
- Gagan MathurOrange$12K
- Grace MonisSacramento$3K
- Jennifer WooIrvine$2K
- Jesse QiaoOrange$2K
- Neil ShahStanford$2K
- Patricia KopkoSan Diego$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.